Benefits of six week and personalized dosing of pembrolizumab considering ongoing delta variant surge.
Sign Up to like & getrecommendations! Published in 2022 at "JPMA. The Journal of the Pakistan Medical Association"
DOI: 10.47391/jpma.4660
Abstract: Dear sir, The on-going discussion on fixed dosing or personalized dosing of pembrolizumab has created great chaos among the patients of metastatic non-small cell lung cancer (NSCLC). Below mentioned are few points in this regard,… read more here.
Keywords: dosing pembrolizumab; delta variant; six week; personalized dosing ... See more keywords